April 10, 2009 (Boston, Massachusetts) — Smoking has become the latest factor shown to affect responsiveness to clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis), with a new post hoc analysis ...
The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use ...
Ann Arbor, MI - The antiplatelet action of clopidogrel appears to be inhibited by the lipid-lowering agent atorvastatin, according to a new study. The authors note that the mechanism involved is ...
A model that combines 3 gene variants involved in clopidogrel metabolism and platelet receptor function with 2 clinical factors—clopidogrel loading dose and use of proton pump inhibitors (PPI)—can ...
ORLANDO -- The widely used herbal remedy St. John's wort appears to amplify the action of the popular blood-thinning drug clopidogrel, sold as Plavix, a small new clinical study finds. The effect ...
Plavix can interact with certain medications like nonsteroidal anti-inflammatory drugs (NSAIDs), certain antidepressants, and others. These interactions can reduce its effectiveness or increase risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results